Methscopolamine

DB11315ApprovedSmall moleculeAnticholinergic Agents

Methscopolamine is a quaternary ammonium derivative of scopolamine and antagonist at muscarininc (mACh) receptors. Methscopolamine bromide is the most common form of the active ingredient in oral pharmaceutical products. The... The oral tablets are used as an adjunct therapy for the treatment of peptic ulcer and is shown to be effective in decreasing the rate of recurrence of peptic ulcers as well as preventing complications.

Chemical structure of Methscopolamine
Formula / weight
C18H24NO4 · 318.392 g/mol (avg)
Also known as
Methylscopolamine

Resolves to

Compound
UNIIVDR09VTQ8UCAS13265-10-6ChEMBLCHEMBL376897ChEBI135361PubChem71183
Clinical / RWD
RxNorm89785ATCA03BB03ATCA03CB01ATCS01FA03
Structure
InChIKeyLZCOQTDXKCNBEE-IKIFYQGPSA-NSMILESC[N+]1(C)[C@H]2C[C@@H](C[C@@H]1[C@H]1O[C@@H]21)OC(=O)[C@H](CO)C1=CC=CC=C1
Targets
P20309CHRM3P08172CHRM2

What you can answer from here — as of August 30, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action
Listed above
516Drug interactionsStructured to mechanism, not free text
Sign in
30Marketed productsAcross 1 country and 13 labellers
Sign in
3ATC codesIncluding every combination product, plus 19 drug categories
Sign in
2+ReferencesStructured and connected to the statements they support
Sign in

Which drugs share a target with Methscopolamine, and which of those have an active Phase 3 trial?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In